🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Open label multicentric randomized phase II trial, using high throughput ge...
Status
Completed
Location
Centre Hospitalier Henri Duffau
Start Date
2014-04-23
Trial ID
NCT02117167
\[Objectives\] Objectives include following to capture safety and efficacy ...
Status
Completed
Location
Multiple Locations
Start Date
2018-05-21
Trial ID
NCT03505307
Comparison of olaparib vs. physician's choice of single agent standard of c...
Status
Completed
Location
Research Site
Start Date
2015-02-06
Trial ID
NCT02282020
Treatments Being Tested
This is a multicenter single-arm phase II clinical trial to evaluate the ef...
Status
Completed
Location
Hospital Universitario Germans Trias i Pujol
Start Date
2017-10-23
Trial ID
NCT03205761
Treatments Being Tested
The purpose of this study is to test the safety of a new medication, Olapar...
Status
Completed
Location
Baptist Alliance Miami Cancer Institute
Start Date
2018-07-12
Trial ID
NCT03532880
Single arm, single site, open-label Phase II study of the effects of oral o...
Status
Recruiting
Location
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Start Date
2019-06-03
Trial ID
NCT03786796
Treatments Being Tested
This phase 1b trial is designed to evaluate the safety and tolerability of ...
Status
Not Yet Recruiting
Location
Peter MacCallum Cancer Centre
Start Date
2025-11-01
Trial ID
NCT07090369
Treatments Being Tested
This is a Phase III randomised, double-blind, multi-centre study to evaluat...
Status
Active Not Recruiting
Location
Research Site
Start Date
2019-01-04
Trial ID
NCT03737643
Treatments Being Tested
To assess the efficacy of olaparib when given in combination with paclitaxe...
Status
Completed
Location
Research Site
Start Date
2010-02-02
Trial ID
NCT01063517
Treatments Being Tested
This study will evaluate the efficacy and safety of olaparib (MK-7339) mono...
Status
Active Not Recruiting
Location
The University of Arizona Cancer Center - North Campus ( Site 0011)
Start Date
2018-12-12
Trial ID
NCT03742895
Treatments Being Tested